• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Furans Furoic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Furans Furoic acid and derivatives Furoic acids

Research Brief on 3-Furancarboxylic acid, 5-(1,1-dimethylethyl)-2-ethyl- (CAS: 1515373-51-9): Recent Advances and Applications

The compound 3-Furancarboxylic acid, 5-(1,1-dimethylethyl)-2-ethyl- (CAS: 1515373-51-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the compound's role as a key intermediate in the synthesis of novel heterocyclic compounds, which are of great interest in medicinal chemistry. The tert-butyl and ethyl substituents on the furan ring contribute to its steric and electronic properties, making it a versatile building block for the development of pharmacologically active molecules. Researchers have successfully employed this compound in the synthesis of inhibitors targeting various enzymes, including kinases and proteases, which are implicated in numerous diseases.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the efficacy of derivatives of 3-Furancarboxylic acid, 5-(1,1-dimethylethyl)-2-ethyl- in modulating the activity of inflammatory pathways. The study revealed that these derivatives exhibit potent anti-inflammatory effects by selectively inhibiting key signaling molecules, suggesting their potential as leads for the development of new anti-inflammatory drugs. Furthermore, the compound's stability and bioavailability were found to be favorable, making it a promising candidate for further optimization.

Another significant advancement was reported in the field of oncology, where derivatives of this compound were shown to inhibit the proliferation of cancer cells in vitro. The mechanism of action involves the disruption of cellular metabolism and induction of apoptosis, as detailed in a recent publication in Bioorganic & Medicinal Chemistry Letters. These findings underscore the compound's potential as a scaffold for the design of anticancer agents, particularly for tumors resistant to conventional therapies.

In addition to its therapeutic potential, 3-Furancarboxylic acid, 5-(1,1-dimethylethyl)-2-ethyl- has also been explored for its utility in material science. Its unique chemical structure allows for the development of novel polymers with enhanced thermal stability and mechanical properties, as reported in a 2022 study in the Journal of Materials Chemistry. This dual applicability in both biomedical and material sciences highlights the compound's versatility and broadens its scope of research.

In conclusion, the latest research on 3-Furancarboxylic acid, 5-(1,1-dimethylethyl)-2-ethyl- (CAS: 1515373-51-9) demonstrates its significant potential in drug discovery and material science. Its structural features enable the development of diverse derivatives with promising biological activities, paving the way for future innovations in the field. Continued research efforts are expected to further elucidate its mechanisms of action and expand its applications, making it a compound of enduring interest in chemical biology and pharmaceutical research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)